Now that Guardant Health Inc’s volume has hit 6.01 million, investors get a glimpse of its size.

On Friday, Guardant Health Inc (NASDAQ: GH) was 13.37% up from the session before settling in for the closing price of $22.51. A 52-week range for GH has been $15.81 – $41.06.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


A company in the Healthcare sector has jumped its sales by 49.27% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 25.81%. With a float of $115.99 million, this company’s outstanding shares have now reached $121.63 million.

In an organization with 1779 employees, it is important to assess its efficiency.

Guardant Health Inc (GH) Insider Updates

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Guardant Health Inc stocks. The insider ownership of Guardant Health Inc is 5.21%, while institutional ownership is 93.59%. The most recent insider transaction that took place on Mar 18 ’24, was worth 38,963. In this transaction Chief Information Officer of this company bought 2,187 shares at a rate of $17.82, taking the stock ownership to the 12,722 shares. Before that another transaction happened on Mar 04 ’24, when Company’s Director sold 100 for $19.05, making the entire transaction worth $1,905. This insider now owns 4,521 shares in total.

Guardant Health Inc (GH) Performance Highlights and Predictions

Going through the last 3-months fiscal report unveiled on the 3/31/2024, it has been observed that the corporation posted -0.67 earnings per share (EPS) during the time that was better than consensus figure (set at -1.17) by 0.5. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.73 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 25.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.20% during the next five years compared to -8.88% drop over the previous five years of trading.

Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators

You can see what Guardant Health Inc (GH) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.17.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.92, a number that is poised to hit -0.74 in the next quarter and is forecasted to reach -2.77 in one year’s time.

Technical Analysis of Guardant Health Inc (GH)

Let’s dig in a bit further. During the last 5-days, its volume was 3.43 million. That was better than the volume of 2.02 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 40.73%. Additionally, its Average True Range was 1.49.

During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 82.29%, which indicates a significant increase from 80.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 89.28% in the past 14 days, which was higher than the 68.09% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $19.41, while its 200-day Moving Average is $24.86. However, in the short run, Guardant Health Inc’s stock first resistance to watch stands at $26.81. Second resistance stands at $28.09. The third major resistance level sits at $29.82. If the price goes on to break the first support level at $23.79, it is likely to go to the next support level at $22.06. Assuming the price breaks the second support level, the third support level stands at $20.77.

Guardant Health Inc (NASDAQ: GH) Key Stats

There are 122,369K outstanding shares of the company, which has a market capitalization of 3.12 billion. As of now, sales total 563,950 K while income totals -479,450 K. Its latest quarter income was 168,490 K while its last quarter net income were -114,990 K.